Metsera (MTSR) Soars to All-Time High on $7.3-Billion Merger With Pfizer
Shares of Metsera Inc. (NASDAQ:MTSR) jumped to a new all-time high on Monday, as investors gobbled up shares following news that it was set to be acquired by Pfizer Inc.
Metsera Inc. (MTSR)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 789,998 | $14,219,964.00 | 8,313,680 | 2025-02-03 | Filing | |
| $18.00 | 1,432,224 | $25,780,032.00 | 18,503,128 | 2025-02-03 | Filing | |
| $18.00 | 789,998 | $14,219,964.00 | 8,313,680 | 2025-02-03 | Filing | |
| $18.00 | 789,998 | $14,219,964.00 | 8,313,680 | 2025-02-03 | Filing | |
| $18.00 | 1,432,224 | $25,780,032.00 | 18,503,128 | 2025-02-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.00 | 268 | $9,648.00 | 0 | 2025-09-02 | Filing |
News See All
Metsera, Inc. (MTSR)’s MET-233i Shows 8% Weight Loss in Phase 1
Metsera, Inc. (NASDAQ:MTSR), a clinical-stage biotech based in New York, is emerging as an innovative player in obesity and metabolic disease treatments.
11 Best Performing Biotech Stocks So Far in 2025
On July 8, Jared Holz of Mizuho spoke on CNBC's "Closing Bell Overtime" about whether the biotech sector is ready for a breakthrough.
11 Best Stocks to Buy for the Next 3 Months According to Hedge Funds
On September 6, Rebecca Patterson, Chief Investment Strategist at Bridgewater Associates, appeared in an interview on CNBC to discuss the current US economy.
Metsera's (MTSR) Amylin Agonist Data Leads to Price Target Increase
Metsera Inc. (NASDAQ:MTSR) is one of the best IPO stocks to buy according to Wall Street analysts.
13 Best IPO Stocks to Buy According to Wall Street Analysts
On August 14, Tony Kim, Centerview Partners co-president, joined CNBC's 'Closing Bell: Overtime' to discuss the IPO market and the dealmaking environment.
Metsera (MTSR) Presented at the 85th Scientific Sessions of the American Diabetes Association
Metsera, Inc. (NASDAQ:MTSR) is one of the 11 Hot New Stocks to Invest in Now. On June 22, Metsera, Inc. (NASDAQ:MTSR) presented at the 85th Scientific Sessions of the American Diabetes Association.
11 Hot New Stocks to Invest in Now
On June 12, Reuters reported that the US IPO market has come to life after a sharp decline since Liberation Day.
Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results
Metsera, Inc. (NASDAQ:MTSR) is one of the 13 Biotech Stocks with Huge Upside Potential. Metsera, Inc.
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
Hedge Fund Resource Center Billionaire Hedge Funds
